| Method | Benefit measured in | Lets you compare |
|---|---|---|
| CEA | Natural units (cases, children, years) | Programmes with the same outcome |
| CUA | DALYs or QALYs | Any health programmes, across diseases |
| CBA | Money (₹) | Anything — health, roads, schools |
| CMA* | (costs only; outcomes assumed equal) | Options with identical effect |
| Perspective | Counts costs to… | Often misses |
|---|---|---|
| Provider | The implementing organisation | Costs borne by participants |
| Participant | The beneficiary — travel, time, fees | Provider overheads |
| Societal | Everyone affected — the fullest view | Hardest to measure fully |
| Source | Strength | Caution |
|---|---|---|
| RCT / trial | Strong causal estimate | May not transfer to your context |
| Quasi-experiment | Real-world, plausible counterfactual | Assumptions can fail |
| Programme monitoring | Cheap, available | No counterfactual |
| Published meta-analysis | Pools many studies | Settings differ from yours |
| Strategy | Cost | Cases detected |
|---|---|---|
| B: standard screening | ₹5,00,000 | 200 |
| A: enhanced screening | ₹8,00,000 | 260 |
| Difference (A − B) | ₹3,00,000 | 60 extra |
| Resource | What it offers |
|---|---|
| Drummond et al., Methods for the Economic Evaluation of Health Care Programmes | The standard textbook of the field |
| WHO-CHOICE | WHO's database and tools for comparing health interventions |
| Disease Control Priorities (DCP3) | Cost-effectiveness evidence across diseases for low/middle-income settings |
| GiveWell & the Disease Control Priorities reviews | Worked 'cost per outcome' analyses you can learn from |
| iDSI Reference Case | A shared standard for credible economic evaluation |